DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Atack JR, Shook BC, Rassnick S. et al.
JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in
preclinical models of Parkinson’s disease.
ACS Chemical Neuroscience 2014;
5: 1005-1019
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.